Translating well into the clinical manifestation, enhanced IFN signaling plays a role in promotion and advancement of autoimmune diseases [37–39], and in fact, STAT1 GOF manifestations have been likened to type I interferonopathies [40]. Here, STAT1 is linked to autoimmune disease.